|
Antimicrobial Usage for Empiric Therapy Please see updated dosing guidelines in the Housestaff Medication Manual Early-onset sepsis (≤72h) Most likely bacteria to cover: E. coli (and other Gram-negative rods), GBS, Listeria. Ampicillin + Gentamicin
- Check trough level prior to 3rd dose
Late-onset sepsis (>DOL3) a) Central line or VP-shunt in place Need to cover coag.-neg. Staph. and Staph. aureus (MSSA/MRSA) First empiric choice:
b) Abdominal infection / Necrotizing enterocolitis (NEC) Most likely bacteria to cover: Gram-negative rods, anaerobes, (coag.-neg. Staph.) First empiric choice:
Ampicillin (or Vancomycin) & Gentamicin
(& Metronidazole (perforation?))
c) Suspected or confirmed meningitis/meningoencephalitis Most likely bacteria to cover: Gram-negative rods, GBS, Listeria, HSV First empiric choice: Ampicillin + Gentamicin + Cefepime (or Cefotaxime) - Add Acyclovir if concern for HSV encephalitis!
d) Possible fungal infection Most likely fungi to cover: Candida albicans, non-albicans Candida, Malassezia First empiric choice: conventional Amphotericin B - Consider Fluconazole or Mycafungin if Amphotericin B not tolerated and Candida albicans. Send isolates for sensitivities (in particular non-albicans Candida)!
Ventilator-associated pneumonia Most likely bacteria to cover: Klebsiella, Enterobacter, Serratia ("KES"), Pseudomonas First empiric choice: Piperacillin/Tazobactam or Cefepime + Gentamicin Consider: Vancomycin if Gram-positive cocci in clusters (coag.-neg. Staph. or MRSA?)
General considerations: 1. Need to pull all lines ASAP for sepsis with Candida, Gram-negative rods, Enterococcus, and persistent coag.-neg. Staph.! Treat 2-3 days before placing new line. 2. Do not forget to obtain urine, CSF, surface cultures, PCR material. 3. Evaluate for metastatic foci of infection (TORCH, GBS, S. aureus, Candida) in thrombi, endocardium, retina, kidney, bones etc. 4. Be aware of tendency of cerebral abscess formation in Citrobacter koseri, Serratia marcesens, and Enterobacter sakazakii meningitis. 5. Beware of resistance development to 3rd generation cephalosporins (due to inducible extended-beta lactamase production). 6. “Double-cover” for SPACEK (Serratia, Pseudomonas, Acinetobacter, Citrobacter, Enterobacter, Klebsiella) organisms. 7. Switch to Meropenem for infections with Gram-negative rods if no response to therapy. 8. Consult Pediatric Infectious Diseases before the horses are out of the barn. J.-H. Weitkamp, 5/2007 |